TotalMarketCap

Citius Pharmaceuticals

CTXRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$15.382 M

$0.56 +1.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Citius Pharmaceuticals (CTXR) has a market capitalization of $15.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

27,452,570

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #393NewcelXNCEL$16.4M
  2. #394Psyence BiomedicalPBM$15.6M
  3. #395Citius PharmaceuticalsCTXR$15.4M
  4. #396Allarity TherapeuticsALLR$15.3M
  5. #397Neuphoria TherapeuticsNEUP$15.1M

What if Citius Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,028,569

Per share 1,835,748× higher

Bitcoin $1.53T

$55,654.10

Per share 99,329× higher

Apple $5.02T

$182,707.21

Per share 326,088× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Citius Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.